MEDICAL MARIJUANA, INC.’s INVESTMENT COMPANY AXIM® BIOTECH RECEIVES APPROVAL FROM MEDICAL ETHICAL COMMITTEE TO BEGIN IBS TRIAL FOR CBD PRODUCT
Company’s Major Investment AXIM Biotech to Begin Study on Patients with IBS with the CanChew Plus® CBD-containing Chewing GumMedical Marijuana, Inc. (OTC: MJNA ), the world’s leading cannabis portfolio company and first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) received approval from the Medical Ethical Committee (METC) of Wageningen University in The Netherlands to begin a study